Crossmark

Can resistance to either isoniazid or rifampicin predict multidrug resistance tuberculosis (MDR-TB)

Published Online: 2023-02-20

Authors

Mchaki, Betty R.

Mgaya, Fauster X.

Kunambi, Peter P.

Matee, Mecky I.
License Information

Text and Data Mining valid from 2023-02-20

Version of Record valid from 2023-02-20
More Information

Article History

Received: 5 December 2022

Accepted: 13 February 2023

First Online: 20 February 2023

Declarations

:

: The ethical consideration was obtained from the Directorate of Research and Publications (DRP) of Muhimbili University of Health and Allied Sciences (MUHAS) in Dar es Salaam, Tanzania (Ref. No. DA.282/298/01.C/named MUHAS-REC-08-2020-344 on 12 August 2020). Permission to use the archived isolates was obtained from the National Tuberculosis and Leprosy Program (NTLP) and Central TB Research Laboratory (CTRL).

: Not applicable.

: The authors do not have any potential, perceived or real competing interests relating to this work.

Document is current